Engineering near-infrared fluorescence optical instrumentation and designing "first-in-humans" imaging agents for translational studies
Wednesday, November 7, 2012
1:30 pm - 2:30 pm
Fitzpatrick Center Schiciano Auditorium Side B
Dr. Eva M. Sevick
Eva M. Sevick, Ph.D. is Professor in Molecular Medicine and Kinder Distinguished Chair at the University of Texas Health Science Center¿s Institute of Molecular Medicine (IMM) where she currently directs the Center for Molecular Imaging. At the IMM she leads the National Cancer Institute Center for Translational Research which focuses upon the development and validation of new imaging instrumentation, algorithms, and imaging agents and their clinical translation. She has pioneered the development of near-infrared fluorescence optical imaging and tomography for molecular imaging and currently has two clinical trials underway at the University of Texas Health Science Center and Memorial Hermann Hospital that employ the technology for novel diagnostic imaging of lymphatic function. Dr. Sevick is currently collaborating with bio-informatics experts to use near-infrared fluorescence lymphatic imaging for phenotyping and next generation sequencing techniques to genotype families with rare lymphatic disorders. Her team is active in preclinical, small animal imaging/tomography with nuclear and optical techniques and is pioneering diagnostic imaging for nodal staging in cancer.